Evolution in the antibiotic susceptibility and resistance;L'evoluzione della sensibilità e della resistenza agli antibiotici

Infezioni in Medicina

Volumn 17, Issue SUPPL. 3, 2009, Pages 5-12

  Stefani, Stefania ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Bacterial resistance; Daptomycin; Gram positive

Indexed keywords

CEFTOBIPROLE; CLINDAMYCIN; DALBAVANCIN; DAPTOMYCIN; LINEZOLID; METICILLIN; OXACILLIN; QUINUPRISTIN; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM STRIATUM; DRUG RESISTANCE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EVOLUTION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; ARTICLE; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS AUREUS;

DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 77949661227     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Finch R.G. Antibiotic resistance: a view from the prescriber. Nature Rev. Microbiol. 2 (12), 989-994, 2004.
2. EARSS, Annual Report 2007. Period of data collection: January 1999-December 2007. Document prepared by the EARSS Management Team, members of the Advisory Board, and national representatives of EARSS, Bilthoven, The Netherlands, October 2008.
3. Rybak M.J., Leonard S.N., Rossi K.L., Cheung C.M., Sader H.S., Jones R.N. Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). Clin. Microbiol. 46 (9), 2950-2954, 2008.
4. Meehl M, Herbert S, Götz F, Cheung A. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51 (8), 2679-2689, 2007. (Pubitemid 47206200)
5. Mwangi M.M., Wu S.W., Zhou Y., et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. USA. 104 (22), 9451-9456, 2007.
6. Moellering R.C. Jr. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46 (7), 1032-1037, 2008. (Pubitemid 351589868)
7. Stevens D.L., Ma Y., Salmi D.B., McIndoo E., Wallace R.J., Bryant A.E. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 195 (2), 202-211, 2007. (Pubitemid 46080052)
8. Dumitrescu O., Boisset S., Badiou C., et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob. Agents Chemother. 51 (4), 19, 2007.
9. Chu V.H., Woods C.W., Miro J.M. et al., and the International Collaboration on Endocarditis-Prospective Cohort Study Group. Emergence of coagulasenegative staphylococci as a cause of native valve endocarditis. Clin. Infect. Dis. 46 (2), 232-242, 2008.
10. Falcone M., Campanile F., Giannella M., Borbone S., Stefani S., Venditti M. Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases. Diagn Microbiol Infect Dis. 57 (3), 325-331, 2007. (Pubitemid 46330650)
11. Mermel L.A., Farr B.M., Sherertz R.J., Raad I.I., O'Grady N., Harris J.H., Craven D.E. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32, 1249-1272, 2001. (Pubitemid 32405897)
12. LaPlante K.L., Mermel L.A. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant. 22 (8), 2239-2246, 2007.
13. Gotz F. Staphylococcus and biofilm. Mol. Microbiol. 43 (6), 1367-1378, 2002.
14. Sutherland I.W. The biofilm matrixan immobilized but dynamic microbial environment. Trend in Microbiol. 9, 111-116, 2001.
15. Raad I., Hanna H., Jiang Y., et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob. Agents Chemother. 51 (5), 1656-1660, 2007.
16. Smith K., Perez A., Ramage G., Gemmell C.G., Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibi otics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int. J. Antimicrob. Agents. 33 (4), 374-378, 2009.
17. Hajdu S., Lassnigg A., Graninger W., Hirschl A.M., Presterl E. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. J. Orthop. Res. 2009.
18. European Antimicrobial Resistance Surveillance System (EARSS), http://www.rivm.nl/earss/Iamges/EARSS%202007-FINAL-tcm61-55933.pdf
19. WHO document at: www.who.int/emc-documents/antimicrobial-resistance/docs/ EGlobal-strat.pdf
20. Campanile F., Carretto E., Barbarini D., et al. Clonal multi-drug resistant Corynebacterium striatum strains, Italy. Emerg. Infect. Dis. (1), 75-78, 2009.
21. Otsuka Y, Ohkusu K., Kawamura Y., Baba S., Ezaki T., Kimura S. Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases. Diagn Microbiol Infect Dis. 54 (2), 109-114, 2006. (Pubitemid 43176600)
22. Lee PP, Ferguson DA Jr, Sarubbi FA. Corynebacterium striatum: an underappreciated community and nosocomial pathogen. J Infect. 50 (4), 338-343, 2005.